India Initiates Probe Against Alleged Dumping of Pharma Raw Material by Chinese Firms



PTI | The Economic Times

New Delhi: India has initiated a probe into alleged dumping of a pharma raw material, Ceftriaxone Sodium Sterile, from China, following complaints by domestic manufacturers.

Nectar Life Sciences and Sterile India have filed an application before the Commerce Ministry’s investigation arm Directorate General of Trade Remedies (DGTR) seeking initiation of the probe.

According to a DGTR notification, the applicants have contended that material injury is being caused to the domestic industry due to dumped imports from China.

They requested imposition of anti-dumping duty on the import.

To read the full article, please click here.